WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (52)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilby, M. J.
Right arrow Articles by Fawcett, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilby, M. J.
Right arrow Articles by Fawcett, J. W.

 Previous Article  |  Next Article 

The Journal of Neuroscience, March 15, 1999, 19(6):2301-2312

A Glial Cell Line-Derived Neurotrophic Factor-Secreting Clone of the Schwann Cell Line SCTM41 Enhances Survival and Fiber Outgrowth from Embryonic Nigral Neurons Grafted to the Striatum and to the Lesioned Substantia Nigra

Martin J. Wilby1, Simon R. Sinclair1, Elizabeth M. Muir2, Rike Zietlow1, 2, Kathryn H. Adcock1, 2, Philippe Horellou4, John H. Rogers2, Stephen B. Dunnett1, 3, and James W. Fawcett1, 2

1 Medical Research Council, Cambridge Centre for Brain Repair, The E. D. Adrian Building, University of Cambridge, Forvie Site, Robinson Way, Hills Road, Cambridge CB2 2PY, United Kingdom, 2 Physiological Laboratory, University of Cambridge, Downing Site, Cambridge CB1 3EG, United Kingdom, 3  Department of Experimental Psychology, University of Cambridge, Downing Site, Cambridge CB2 3EG, United Kingdom, and 4 C 9923 Centre National de la Recherche Scientifique, Laboratoire de Genetique Moleculaire de la Neurotransmission et des Processus Degeneratifs, Hopital de la Pitie Salpetriere, Batiment CERVI, 75013 Paris, France.

We have developed a novel Schwann cell line, SCTM41, derived from postnatal sciatic nerve cultures and have stably transfected a clone with a rat glial cell line-derived neurotrophic factor (GDNF) construct. Coculture with this GDNF-secreting clone enhances in vitro survival and fiber growth of embryonic dopaminergic neurons. In the rat unilateral 6-OHDA lesion model of Parkinson's disease, we have therefore made cografts of these cells with embryonic day 14 ventral mesencephalic grafts and assayed for effects on dopaminergic cell survival and process outgrowth. We show that cografts of GDNF-secreting Schwann cell lines improve the survival of intrastriatal embryonic dopaminergic neuronal grafts and improve neurite outgrowth into the host neuropil but have no additional effect on amphetamine-induced rotation. We next looked to see whether bridge grafts of GDNF-secreting SCTM41 cells would promote the growth of axons to their striatal targets from dopaminergic neurons implanted orthotopically into the 6-OHDA-lesioned substantia nigra. We show that such bridge grafts increase the survival of implanted embryonic dopaminergic neurons and promote the growth of axons through the grafts to the striatum.

Key words: bridge graft; GDNF; Parkinson's disease; 6-OHDA; Schwann cells; SCTM41; substantia nigra; neuronal graft


Copyright © 1999 Society for Neuroscience  0270-6474/99/1962301-12$05.00/0


This article has been cited by other articles:


Home page
BrainHome page
S. Johansson, I-H. Lee, L. Olson, and C. Spenger
Olfactory ensheathing glial co-grafts improve functional recovery in rats with 6-OHDA lesions
Brain, December 1, 2005; 128(12): 2961 - 2976.
[Abstract] [Full Text] [PDF]


Home page
Neurorehabil Neural RepairHome page
W. -L. Kuan and R. A. Barker
New Therapeutic Approaches to Parkinson's Disease Including Neural Transplants
Neurorehabil Neural Repair, September 1, 2005; 19(3): 155 - 181.
[Abstract] [PDF]


Home page
IOVSHome page
J. M. Lawrence, D. J. Keegan, E. M. Muir, P. J. Coffey, J. H. Rogers, M. J. Wilby, J. W. Fawcett, and R. D. Lund
Transplantation of Schwann Cell Line Clones Secreting GDNF or BDNF into the Retinas of Dystrophic Royal College of Surgeons Rats
Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 267 - 274.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. Nikkhah, G. Falkenstein, and C. Rosenthal
Restorative Plasticity of Dopamine Neuronal Transplants Depends on the Degree of Hemispheric Dominance
J. Neurosci., August 15, 2001; 21(16): 6252 - 6263.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. Kirik, C. Winkler, and A. Bjorklund
Growth and Functional Efficacy of Intrastriatal Nigral Transplants Depend on the Extent of Nigrostriatal Degeneration
J. Neurosci., April 15, 2001; 21(8): 2889 - 2896.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
P. Brundin, O. Pogarell, P. Hagell, P. Piccini, H. Widner, A. Schrag, A. Kupsch, L. Crabb, P. Odin, B. Gustavii, et al.
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease
Brain, July 1, 2000; 123(7): 1380 - 1390.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-